Pharmaceuticals

Fabrx demonstrates pharmaceutical 3D printing in community pharmacy Voxel Matters05:43
Oncimmune CEO on 2025 growth and new deals - ICYMI Proactive Investors (UK)00:55
Musk is helping his friends in the financial industry – Oped Eurasia Review20:41
Johnson & Johnson Innovative Medicine named Cork Chamber Company of the Year Irish Examiner18:30
Hims & hers Super Bowl Ad under fire from trade group, senators Adweek18:14
Study finds fasting plasma glucose level is associated with development of diabetes Pharmacy Times16:13
Ninety percent of drugs fail clinical trials. Can AI help? 3 Quarks Daily10:41

Latest News

In the last 15 minutes

Lundbeck's covert mission to bring home kidnapped psychiatrist Keith Siegel from Gaza Jerusalem Post07:02

In the last hour

Is Summit Therapeutics a Millionaire Maker? The Motley Fool06:25

In the last 2 hours

Is Now a Good Time to Buy the Dip on Pfizer? The Motley Fool06:04

3 Dividend Stocks to Double Up on Right Now The Motley Fool05:44

In the last 4 hours

H. Lundbeck (CPH:HLUN B) Is Paying Out A Larger Dividend Than Last Year Simply Wall St04:53

Turn whistle-blowers & call out bad elements selling spurious products, Commerce Minister tells pharma industry The Hindu Business Line04:43

Incorporating health literacy principles into the adaptation of a methods motivational interviewing approach for… Nature.com04:39

India's pharma exports set for 10x growth, targeting $350 billion by 2047 The Business Standard04:06

In the last 6 hours

Intel and Pfizer in Ireland show business is about more than Trump trade wars The Irish News03:00

India's Cdmo market set to double by 2028 amid Asia's healthcare boom AniNews.in02:59

India’s pharma exports has potential to reach $350 billion by 2047: Report DD News02:47

Earlier today

Bitter Pill: US opioid crisis remains despite settlement RTE01:05

How drug labs in China ignited Trump’s global trade war The Sydney Morning Herald00:30

In the last 8 hours

Bain to acquire Mitsubishi Tanabe Pharma in $3.3 billion deal The Japan Times23:49 8-Feb-25

Edinburgh MP Scott Arthur reveals details of Rare Cancers Bill he will present in Westminster Edinburgh Evening News23:45 8-Feb-25

Yesterday

New clinical trial aims to improve outcomes for older adults with hip fractures News-Medical.Net21:22 8-Feb-25

Arizona AG accuses asthma drug maker of scheming to avoid Medicaid rebates KTAR.com, Arizona20:08 8-Feb-25

Common American medicines won’t be spared from Trump’s tariffs The Independent18:21 8-Feb-25

AbbVie wins FDA approval for new antibiotic ENDPOINTS14:42 8-Feb-25

Teva signals return to fundraising after decade-long crisis CTech13:01 8-Feb-25

Band-Aids marketed to people of color contain harmful chemicals, lawsuit says NJ.com - The Jersey Journal11:40 8-Feb-25

Empowering fight against breast cancer through pharmaceutical innovation and public health… Vanguard, Nigeria10:34 8-Feb-25

Nipocalimab Demonstrates Sustained Disease Control, Reduction in Autoantibodies in Generalized Myasthenia Gravis Pharmacy Times10:11 8-Feb-25

Pharma exports expected to double to $65 billion by 2030: Report The Times of India09:23 8-Feb-25

AstraZeneca, Whitehall, and a failed £450m deal for the next generation in vaccines. What went… Yahoo! UK & Ireland09:10 8-Feb-25

2 Stocks That Could Soar Again in 2025 The Motley Fool08:54 8-Feb-25

Pharma exports to touch $65 bn mark by 2030, $350 bn by 2047: Report The Business Standard08:35 8-Feb-25

These 2 Dividend Stocks Are Absolute Bargains Right Now The Motley Fool08:34 8-Feb-25

The OncFive: Top Oncology Articles for the Week of 2/2 OncLive08:14 8-Feb-25

Similar Survival, Safety for Bevacizumab Biosimilar vs Originator in Colorectal Cancer Center for Biosimilars07:22 8-Feb-25

What are nutraceuticals and why are they gaining popularity in India The Times of India07:00 8-Feb-25

Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the Akt/GSK3β/β-catenin… Nature.com06:32 8-Feb-25

Is Novo Nordisk Stock a Buy Now? The Motley Fool06:11 8-Feb-25

Q4 earnings updates; Biogen details revised research strategy; RFK Jr. advances out of Senate committee; and more ENDPOINTS06:04 8-Feb-25

FABRX demonstrates pharmaceutical 3D printing in community pharmacy Voxel Matters05:43 8-Feb-25

AstraZeneca Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags Simply Wall St04:30 8-Feb-25

Oncimmune CEO on 2025 growth and new deals - ICYMI Proactive Investors (UK)00:55 8-Feb-25

In the last 7 days

Pharmacists Protest Sealing of Premises By Benue Govt ThisDay Live22:09 7-Feb-25

Musk Is Helping His Friends In The Financial Industry – OpEd Eurasia Review20:41 7-Feb-25

Genetic Diversity in African Populations Can Advance Precision Medicine Globally Pharmacy Times20:37 7-Feb-25

Novo Nordisk praised for boosting bilateral ties Bangkok Post20:28 7-Feb-25

Fed. Circ. Backs Ventria Cell Culture Patent Win At ITC Law36019:35 7-Feb-25

A new wearable treatment for Parkinson’s motor fluctuations Knowridge Science Report19:17 7-Feb-25

Methods to address functional unblinding of raters in CNS trials Nature.com18:46 7-Feb-25

Unveiling the Dark Genome: Targeting Stress-Activated Base Editors to Halt Cancer Progression Pharmacy Times18:45 7-Feb-25

Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool” American Journal of Managed Care18:38 7-Feb-25

Johnson & Johnson Innovative Medicine named Cork Chamber Company of the Year Irish Examiner18:30 7-Feb-25

Hims & Hers Super Bowl Ad Under Fire From Trade Group, Senators Adweek18:14 7-Feb-25

Sionna IPO Grosses $191m To Compete With Vertex In CF Scrip Pharma Intelligence18:05 7-Feb-25

Alumis To Merge With Acelyrin, But Pause Lonigutamab Program Scrip Pharma Intelligence18:05 7-Feb-25

Pharmaceuticals become a battlefield in the Sino-US trade war Asia Times18:04 7-Feb-25

Finally, FDA’s Final Word on Unapproved Use Communications JD Supra18:03 7-Feb-25

Eye-Catching: Biosimilars Injunction Prevails JD Supra17:53 7-Feb-25

Wall Street Analysts Thought Merck Stock Had 10% Downside Risk Heading Into Earnings. That… 24/7 Wall St.17:23 7-Feb-25

Mayes accuses British drugmaker of skirting prescription pricing laws in new lawsuit KJZZ16:39 7-Feb-25

Henipaviruses: Understanding a Genus of Emerging Zoonotic Threats Disabled World News16:35 7-Feb-25

EU Biosimilar Regulatory and Launch Updates JD Supra16:21 7-Feb-25

Study Finds Fasting Plasma Glucose Level Is Associated With Development of Diabetes Pharmacy Times16:13 7-Feb-25

Recipharm Launches New Fully Operational Modular Sterile Filling System in Germany PharmTech.com16:12 7-Feb-25

Chinese Plant Protein Product Infringes Patent, Says Fed. Cir. Bloomberg Law16:02 7-Feb-25

Senators ask FDA to dig into 'misleading' Super Bowl ad from Hims ENDPOINTS15:41 7-Feb-25

Q&A: Wayne Batchelor Reflects on the State of Medical Research Early in the Second Trump Term TCTMD15:15 7-Feb-25

Aztreonam and Avibactam Receive FDA Approval for Treatment of Adults With Complicated Intra-Abdominal Infections Pharmacy Times15:12 7-Feb-25

Post-Hoc: China tensions both help and hurt Illumina ENDPOINTS15:11 7-Feb-25

Sanofi, AstraZeneca back Teva's call to rehear case on patent listings ENDPOINTS15:11 7-Feb-25

Eastern Maine Medical Center v. TEVA Pharmaceuticals USA U.S. Chamber of Commerce (Press Release)15:07 7-Feb-25

FDA Issues Early Alert About Risks of Peripheral Atherectomy Device TCTMD15:04 7-Feb-25

US FDA approves AbbVie-Pfizer's treatment for intra-abdominal infections KELO TV14:52 7-Feb-25

Major FDA staff cuts would slow drug reviews, experts say ENDPOINTS14:51 7-Feb-25

Running on Ice: Chinese tariffs’ impact on the pharmaceutical supply chain Yahoo! US14:40 7-Feb-25

Doctors complete fourth xenotransplant of gene-edited pig kidney ENDPOINTS14:30 7-Feb-25

AdvanCell Completes $112 Million Oversubscribed Series C Financing PharmTech.com14:30 7-Feb-25

How ViiV Healthcare plans to ‘show up even better’ in the fight against HIV in Black communities FiercePharma14:10 7-Feb-25

A Second Patient Received a Pig Kidney TIME14:08 7-Feb-25

Ifetroban Improves Heart Function in DMD American Journal of Managed Care13:53 7-Feb-25

'Hypocrite' Democrat prosecutor scored $25 million from billionaire father's drug firm… MailOnline13:42 7-Feb-25

BioNTech Acquires Biotheus To Boost Oncology Strategy JD Supra13:39 7-Feb-25

Why Aren't More EDs Prescribing Medication for Elective Abortion? Medpage Today13:32 7-Feb-25

Biologic could reduce treatment burden for children with haemophilia A European Pharmaceutical Review13:28 7-Feb-25

Belgian regulator recommends blocking Indian drugmaker's API production ENDPOINTS13:19 7-Feb-25

Quadruple Therapy With Isatuximab Shows Promise for Older Adults With Multiple Myeloma Pharmacy Times13:10 7-Feb-25

Here's Why You Should Retain Glaukos Stock in Your Portfolio Now Zacks13:05 7-Feb-25

Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards? Zacks13:05 7-Feb-25

FDA Grants Breakthrough Device Designation to Serial CTRS AI Model for NSCLC OncLive12:46 7-Feb-25

Centre organises consultation with States on biomanufacturing The Hindu12:39 7-Feb-25

Inside AstraZeneca’s abandoned £450m vaccine plant deal The Independent12:27 7-Feb-25

MD Anderson Study Resumes With Seclidemstat/Azacitidine in MDS/CMML OncLive12:25 7-Feb-25

BioWorld and Nasdaq stock indices BioWorld12:21 7-Feb-25

Pharmacists Can Stay Aware of the Evolving Landscape of Gout Treatment to Address Unmet Needs Pharmacy Times12:19 7-Feb-25

Teva, Cipla Deal on Inhaler Resolves Clash Over Targeted Patents Bloomberg Law12:18 7-Feb-25

5 Things You Should Do in Late Winter to Ensure a Lush Lawn Come Spring Real Simple12:17 7-Feb-25

Impact of proposed US tariffs on pharmaceutical FDI in Canada, Mexico, China and Europe Pharmaceutical Technology12:10 7-Feb-25

The Tourette’s Deal That Came Too Late To Save Sweden’s Asarina Scrip Pharma Intelligence11:59 7-Feb-25

The AQUILA Debate: Daratumumab and Smoldering Multiple Myeloma Pharmacy Times11:59 7-Feb-25

Bioluminescence Ventures to shut down 15 months after launch ENDPOINTS11:57 7-Feb-25

Sanofi increases ownership stake partaking in pharma buyback trend Pharmaceutical Technology11:50 7-Feb-25

Roche details Gazyva's positive data en route to key lupus nephritis expansion FiercePharma11:49 7-Feb-25

The Forgotten—and Incredibly Important—History of the Abortion Pill Mother Jones11:40 7-Feb-25

Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma FiercePharma11:38 7-Feb-25

Rwanda: Kagame, Egyptian Drug Company Boss Discuss Partnership AllAfrica11:37 7-Feb-25

J&J CEO broke a stalemate and facilitated the $14.6B Intra-Cellular buyout in a whirlwind… FiercePharma11:28 7-Feb-25

Obesity market growing but investors eye what’s next BusinessDesk11:21 7-Feb-25

States to set up centres for effective implementation of BioE3 policy: Jitendra Singh The Times of India11:11 7-Feb-25

10 Clinical Trials To Look Out For In 2025 Scrip Pharma Intelligence11:08 7-Feb-25

Bain buys Mitsubishi Tanabe Pharma in $3.3B bet on Japan ENDPOINTS11:07 7-Feb-25

Alkem Labs acquires two companies specialising in skin care, medtech to bolster domestic… The Times of India11:02 7-Feb-25

Highest SMM Rates in Pregnant People With Chronic Hypertension and Preeclampsia, Preeclampsia Alone Pharmacy Times10:48 7-Feb-25

Ninety percent of drugs fail clinical trials. Can AI help? 3 Quarks Daily10:41 7-Feb-25

Super Bowl Ad Raises Questions About Compounded Versus Branded Obesity Meds Forbes10:21 7-Feb-25

FDA Grants Fast Track Designation to ADI-001 for Treatment of Refractory Systemic Lupus Erythematosus Pharmacy Times10:18 7-Feb-25

ABO-101 Receives FDA Orphan Drug and Rare Pediatric Designations for Primary Hyperoxaluria Type 1 Pharmacy Times10:18 7-Feb-25

FDA approves ‘first’ of new class of non-addictive drugs for severe pain The Chemical Engineer10:17 7-Feb-25

Centre rolls back traceability system for pharma exports, experts caution against ‘conflicting signals’ The Hindu Business Line09:56 7-Feb-25

FDA approves treosulfan with fludarabine as a preparative regimen for alloHSCT in adult and… ecancer09:41 7-Feb-25

USAID could see workforce cut to 600 as stop-work looms pharmaphorum09:19 7-Feb-25

view more headlines

9 Feb 07:02

About our Pharmaceuticals news

NewsNow aims to be the world's most accurate and comprehensive pharmaceutical news aggregator, bringing you the latest headlines from the best pharma sites and other key national and regional news sources. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication.

Pharmaceuticals

Latest News

About our Pharmaceuticals news

Business Top Stories